{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:57:34Z","timestamp":1773269854076,"version":"3.50.1"},"reference-count":97,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T00:00:00Z","timestamp":1378425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Tremendous strides have been made in improving the outcomes of haematological malignancies (<jats:styled-content style=\"fixed-case\">HM<\/jats:styled-content>) over the last three decades, but adolescents and young adult (<jats:styled-content style=\"fixed-case\">AYA<\/jats:styled-content>) patients have not benefitted equally compared to younger and older patients. Excellent outcomes in <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>odgkin lymphoma have allowed tailoring of highly effective regimens that limit the incidence of late effects. Early successes in paediatric acute lymphoblastic leukaemia set the stage for a series of studies in young adults utilizing a paediatric\u2010type treatment strategy. These studies have determined that <jats:styled-content style=\"fixed-case\">AYA<\/jats:styled-content>s benefit from paediatric\u2010type chemotherapy regimens. Despite the increased incidence of acute myeloid leukaemia and non\u2010Hodgkin lymphoma in the <jats:styled-content style=\"fixed-case\">AYA<\/jats:styled-content> age group, optimal strategies for these patients have not been systematically pursued. There is renewed interest in improving <jats:styled-content style=\"fixed-case\">HM<\/jats:styled-content> outcomes in <jats:styled-content style=\"fixed-case\">AYA<\/jats:styled-content> patients and this will rely on the development of clinical trials that specifically target these patients. Understanding and addressing the unique psychosocial challenges of this population will be critical in supporting this endeavor.<\/jats:p>","DOI":"10.1111\/bjh.12556","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T07:29:33Z","timestamp":1378452573000},"page":"3-14","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Therapeutic approaches to haematological malignancies in adolescents and young adults"],"prefix":"10.1111","volume":"164","author":[{"given":"Andrew E.","family":"Place","sequence":"first","affiliation":[{"name":"Dana\u2010Farber Cancer Institute Boston MA USA"},{"name":"Department of Pediatrics Harvard Medical School Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha N.","family":"Frederick","sequence":"additional","affiliation":[{"name":"Dana\u2010Farber Cancer Institute Boston MA USA"},{"name":"Department of Pediatrics Harvard Medical School Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"Sallan","sequence":"additional","affiliation":[{"name":"Dana\u2010Farber Cancer Institute Boston MA USA"},{"name":"Department of Pediatrics Harvard Medical School Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,9,6]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2012.705891"},{"key":"e_1_2_12_3_1","unstructured":"Adolescent and Young Adult Oncology Progress Review Group(2006)Closing the gap: Research and care imperatives for adolescents and young asults with cancer \u2013 Report of the Adolescent and Young Adult Oncology Progress Review Group.National Cancer Institute (USA) Bethesda MD."},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-041012"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2003.09.013"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.7231"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004063421402"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.1325"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.55.5.469"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.4560"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq677"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.6397"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70377-7"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.57.4.242"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22190"},{"key":"e_1_2_12_16_1","volume-title":"Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975\u20132000","author":"Bleyer A.","year":"2006"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22104"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.053"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403538"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-115493"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.1487"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.2907"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70344-3"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23031"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23220"},{"key":"e_1_2_12_26_1","first-page":"587","article-title":"A multicenter phase II study using a dose intensified pediatric regimen in adults with untreated acute lymphoblastic leukemia","volume":"110","author":"DeAngelo D.J.","year":"2007","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24446"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.3266"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.2655"},{"key":"e_1_2_12_30_1","first-page":"534","volume-title":"Cancer in Adolescents and Young Adults","author":"Eiser C.","year":"2007"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1000067"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904544"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.5823"},{"key":"e_1_2_12_34_1","first-page":"183","article-title":"Outcome of adolescents and young adults (AYAs) with non\u2010M3 acute myeloid leukemia (AML) treated on Children's Oncology Group (COG) trials compared to Cancer and Leukemia Group B (CALGB) and Southwest Oncology Group (SWOG) trials","volume":"116","author":"Franklin A.R.K.","year":"2010","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.071597"},{"key":"e_1_2_12_36_1","first-page":"905","article-title":"No increase in age\u2010specific incidence of myelodysplastic syndromes","volume":"89","author":"Germing U.","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-422709"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116582"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.4803"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.1297"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07417.x"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08724.x"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-184747"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2011.0086"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.6916"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.361"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.8018"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2009.07.009"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-012-0238-6"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.813"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.5598"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000141301"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.11.075"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.5999"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300874"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21817"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-444851"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-7-816"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.9381"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199410063311402"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf253"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5847"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.7114"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930515)71:10 <3377::AID-CNCR2820711741>3.0.CO;2-8"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.8959"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.2954"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.6333"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-036673"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.6929"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21462"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.0325"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20749"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26048"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21892"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.7265"},{"key":"e_1_2_12_76_1","first-page":"858","article-title":"Efficacy and toxicity of rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or Burkitt \u2013 like leukemia\/lymphoma: Cancer and Leukemia Group B (Calgb) study 10002","volume":"116","author":"Rizzieri D.A.","year":"2010","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1623"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.77"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.2514"},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.10.60"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.3699"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1300\/J077v25n03_06"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26634"},{"key":"e_1_2_12_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1211"},{"key":"e_1_2_12_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27684"},{"key":"e_1_2_12_86_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00075"},{"key":"e_1_2_12_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-130237"},{"key":"e_1_2_12_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07712.x"},{"key":"e_1_2_12_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21776"},{"key":"e_1_2_12_90_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12466"},{"key":"e_1_2_12_91_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.2070"},{"key":"e_1_2_12_92_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.8.2685"},{"key":"e_1_2_12_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-283093"},{"key":"e_1_2_12_94_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20646"},{"key":"e_1_2_12_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22940"},{"key":"e_1_2_12_96_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0410"},{"key":"e_1_2_12_97_1","first-page":"534","volume-title":"Cancer in Adolescents and Young Adults","author":"Zebrack B.","year":"2007"},{"key":"e_1_2_12_98_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.5467"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.12556","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.12556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T23:59:56Z","timestamp":1696291196000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.12556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,6]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.1111\/bjh.12556"],"URL":"https:\/\/doi.org\/10.1111\/bjh.12556","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,6]]},"assertion":[{"value":"2013-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-08-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-09-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}